Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005-2016
Our recent RWE study detailed the comorbidity burden of Finnish multiple myeloma (MM) patients diagnosed between 2005 and 2016.
Tatu has worked at Medaffcon since August as an intern. He holds a Master’s Degree in Economics and Business Administration and is currently finalizing his Health Economics studies in the University of Eastern Finland.
Before joining Medaffcon Tatu has worked in the pharmaceutical industry at Boehringer Ingelheim as an Account Manager with diabetes, respiratory and anticoagulation treatment portfolios.
We want to welcome Tatu to our growing team!
Our recent RWE study detailed the comorbidity burden of Finnish multiple myeloma (MM) patients diagnosed between 2005 and 2016.
How to review and analyse a million sentences? Text mining decreased the work of clinical experts and accelerated the research process.
Heini Honkanen has been appointed as Medaffcon’s Market Access Lead. The new Market Access Team was created when the previous Price and Reimbursement and HE & Access Teams were merged.